Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
Betül Toprak(Universität Hamburg), Renate B. Schnabel(Universität Hamburg), Wolfgang Köenig(Brigham and Women's Hospital), Stefan Blankenberg(Universität Hamburg), Augusto Di Castelnuovo, Maja‐Lisa Løchen, Licia Iacoviello(Libera Università Maria SS. Assunta), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Stephan Camen(Universität Hamburg), Stephanie Brandt(Universität Hamburg), Tanja Zeller(Universität Hamburg), Stefan Söderberg(Umeå University), Allan Linneberg(University of North Carolina at Chapel Hill), Jukka Kontto(Finnish Institute for Health and Welfare), Ellisiv B. Mathiesen(UiT The Arctic University of Norway), Maria Benedetta Donati(Istituto Neurologico Mediterraneo), Erkki Vartiainen(Unknown), Veikko Salomaa(Finnish Institute for Health and Welfare), Jan Brederecke(Universität Hamburg), Julie K.K. Vishram‐Nielsen(Frederiksberg Hospital), Ioannis Katsoularis(Umeå University), Martin Bobák(Masaryk University), Christin S. Börschel(Universität Hamburg), Teemu Niiranen(Edinburgh Napier University), Francesco Gianfagna(University of Insubria), Giovanni de Gaetano(Istituto Neurologico Mediterraneo), Francisco Ojeda, Simona Costanzo(Istituto Neurologico Mediterraneo)
Cited by 18
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k